Botanix Pharmaceuticals Limited (ASX:BOT)
Australia · Delayed Price · Currency is AUD 0.0240
+0.0010 (4.35%)
May 29, 2026, 4:11 PM AEST
Botanix Pharmaceuticals Stock Forecast
ASX-BOT's stock price has decreased by -93.68% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, Botanix Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $0.49. The average 1-year stock price forecast is 1,941.67% higher than the current stock price, while the lowest is $0.14 (+483.33%) and the highest is $1.00 (+4,066.67%).
Price Target: $0.49 (+1,941.67%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Botanix Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $0.14 | Buy | Maintains | $0.14 | +483.33% | May 4, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $1.00 | Buy | Reiterates | $1.00 | +4,066.67% | Apr 29, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.